Peroxisome proliferator-activated receptor-γ2 (PPARγ) polymorphism Pro12Ala and diabetic nephropathy in Type 1 diabetic patients in the FinnDiane Study

被引：0
|
作者：
Forsblom, CM
Fröjdö, S
Parkkonen, M
Pettersson-Fernholm, K
Fagerudd, J
Groop, PH
机构：
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, FIN-00014 Helsinki, Finland
[2] Folkhalsan Res Ctr, Helsinki, Finland
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
968
引用
收藏
页码：A334 / A335
页数：2
相关论文
共 50 条
  • [1] The peroxisome proliferator-activated receptor-γ2 pro12Ala polymorphism
    Stumvoll, M
    Häring, H
    DIABETES, 2002, 51 (08) : 2341 - 2347
  • [2] No association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 with diabetic nephropathy in Japanese diabetic subjects
    Tamemoto, H
    Namai, K
    Saitoh, T
    Ishikawa, SE
    Kawakami, M
    DIABETES, 2005, 54 : A206 - A206
  • [3] Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and risk for pediatric obesity
    Dedoussis, George V.
    Vidra, Nikoleta
    Butler, Johannah
    Papoutsakis, Constantina
    Yannakoulia, Mary
    Hirschhorn, Joel N.
    Lyon, Helen N.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (09) : 1047 - 1050
  • [4] The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes
    Caramori, ML
    Canani, LH
    Costa, LA
    Gross, JL
    DIABETES, 2003, 52 (12) : 3010 - 3013
  • [5] The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
    Andersen, G
    Ek, J
    Urhammer, SA
    Eiberg, H
    Borch-Johnsen, K
    Hansen, T
    Pedersen, O
    DIABETOLOGIA, 2000, 43 : A87 - A87
  • [6] Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population
    Zhou, Tian-Biao
    Guo, Xue-Feng
    Yin, Sheng-Sheng
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2014, 34 (03) : 180 - 184
  • [7] Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes
    Pollex, Rebecca L.
    Mamakeesick, Mary
    Zinman, Bernard
    Harris, Stewart B.
    Hegele, Robert A.
    Hanley, Anthony J. G.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 166 - 171
  • [8] Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk
    Wang, Wei
    Shao, Yan
    Tang, Shenhua
    Cheng, Xianyong
    Lian, Haifeng
    Qin, Chengyong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4066 - 4072
  • [9] Peroxisome proliferator-activated receptor. Pro12Ala polymorphism decrease the risk of diabetic nephropathy in type 2 diabetes: a meta analysis
    Ding, Jiarong
    Zhu, Chao
    Mei, Xiaobin
    Zhou, Yangyang
    Feng, Bing
    Guo, Zhiyong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7655 - 7660
  • [10] Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-γ2 in Korean diabetic and obese subjects
    Oh, EY
    Min, KM
    Chung, JH
    Min, YK
    Lee, MS
    Kim, KW
    Lee, MK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05): : 1801 - 1804
12345